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Kathryn B. Garber1,*Reverse Diagnosis of Lynch Syndrome Mutations
Mutations in several mismatch-repair genes cause Lynch
syndrome, but not all sequence variation in these genes
causes disease. Unfortunately, it can sometimes be difficult
to tell in which category a variant should be placed. Once
a variant is found in an affected individual, the experiments
needed to measure the effect of a single variant on protein
function are time consuming and impractical for a diag-
nostic lab, whichmeans that variants often go unclassified.
Drost et al. flipped this approach on its head. They used
a cell-culture system to identify critical residues in the
mismatch-repair gene Msh2 so that it might inform the
interpretation of variation found in affected individuals.
Mouse embryonic stem cells containing a single allele of
Msh2 were mutagenized with ENU, and cells with a second
hit in the genewere isolated via selection. Deleteriousmuta-
tions at a total of 23 amino acid residueswere identified, and
thesewere characterized extensively in a series of functional
assays.Of these residues, variationat11hasbeen reported in
individuals suspected of having Lynch syndrome. Although
this is most likely not a complete catalog of the critical resi-
dues in Msh2, this ‘‘reverse diagnosis catalog’’ of mutations
provides another source of data for the interpretation of
sequence variation in MSH2, and the same system can be
used for cataloging variation in other relevant mismatch-
repair genes.
Drost et al. (2013). Proc. Natl. Acad. Sci. USA 110, 9403–
9408.
New Database of Conditions Is Based on Clinical
Utility of Genetic Diagnosis
As the debate about the return of incidental findings from
genomic testing rages on, one issue that is sometimes
overlooked is the challenge of picking out the sequence
variation that has clinical significance from among the
reams of data. To manage this issue, Solomon et al. from
the National Human Genome Research Institute con-
structed a manually curated database of single-gene condi-
tions according to available clinical interventions. They
call it the Clinical Genomic Database (CGD). Each entry
links to many of the well-known genetic databases, such
as OMIM, GeneReviews, and the 1000 Genomes Project,
which can be used for further information. As opposed to
these other databases, CGD focuses on currently available
interventions and their rationale. More than 2,600 genes
are already included in the database, and for over half of1Department of Human Genetics, Emory University School of Medicine, Atlan
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is available: (1) the condition caused by mutations in the
gene is clinically significant; (2) there is a currently avail-
able, potentially beneficial intervention; and (3) genetic
diagnosis has an advantage over symptom-based diagnosis.
CGDwill be regularly updated, and the curators are seeking
comments on individual entries from content experts.
Solomon et al. (2013). Proc. Natl. Acad. Sci. USA 110, 9851–
9855.
Gene in Prader-Willi Syndrome Critical Region Is
Responsible for Precocious Puberty
Estimates suggest that at least one-quarter of cases of preco-
cious puberty are familial, but the underlying genetic expla-
nation is almost always elusive. Mutations in two genes
have been reported but are detected in only a very limited
number of individuals with early puberty. Expecting auto-
somal-dominant inheritance, Abreu et al. used an exome-
based approach to identify the responsible mutations in
15 families affected by central precocious puberty. In five
of the families, they found point mutations in MKRN3, an
imprinted gene that resides in the Prader-Willi syndrome
(PWS) critical region. Consistent with the paternal expres-
sion of this gene, mutation carriers were affected only
when the mutation was inherited from their fathers. If
loss of function of this gene causes precocious puberty,
why is this not a hallmark feature of PWS? In fact, preco-
cious puberty has been reported in a small number of
PWS cases. Most affected individuals, however, have hypo-
gonadism due to hypothalamic dysfunction, and this is, in
fact, a major clinical diagnostic criteria for PWS. Many of
these individuals do not spontaneously complete puberty
at all, nevermind early. Thus, the effects on sexual develop-
ment of the additional genes deleted in PWS appear to be
epistatic to loss of MKRN3, possibly because there is a
more fundamental defect in hypothalamic function.
Abreu et al. (2013). N. Engl. J. Med. Published online June 5,
2013. http://dx.doi.org/10.1056/NEJMoa1302160.
The Same Somatic Mutation Causes Sturge-Weber
Syndrome and Isolated Port-Wine Stains
Port-wine stains of the skin are not uncommon capillary
malformations that cause skin discoloration. Generally,
they occur in isolation, but, particularly if distributed
along the ophthalmic branch of the trigeminal nerve,
they can be a part of Sturge-Weber syndrome, in whichta, GA 30322, USA
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there are also intracranial vascular anomalies that
commonly cause epilepsy and glaucoma. Both conditions
are thought to result from somatic mutations. To identify
the underlying causes, Shirley et al. performed whole-
genome sequencing of affected tissues and compared the
results to the sequence from unaffected tissues of the
same individuals. In GNAQ, an identical missense change
that activates signaling through the encoded protein was
found in affected tissues from the majority of individuals
with either condition. Presumably, the timing and location
of the mutation during development determines the
extent of the phenotype.
Shirley et al. (2013). N. Engl. J. Med. 368, 1971–1979.
Like Mother, Not Like Daughter?
A fundamental idea of biology is that DNA replication
generates two identical strands of DNA. How, then, can
there be asymmetric segregation of the resulting chroma-
tids during cell division? Adapting a fluorescence in situ hy-
bridization procedure that uses strand-specific probes,4 The American Journal of Human Genetics 93, 3–4, July 11, 2013Yadlapalli and Yamashita describe this phenomenon in
male germline stem cells (GSCs) of Drosophila. Although
sister chromatids of the autosomes segregate randomly
when these cells divide, there is biased segregation for the
X and Y chromosomes in that GSCs retain the same sister
chromatid 85% of the time. Mutations in components of
the centrosome and of the complex that tethers the
nucleus to the cytoskeleton randomize chromatid segrega-
tion, leading the authors to propose that the individual sis-
ter chromatids are recognized in some fashion and that one
is tethered to themother centrosome, which is inherited by
GSCs. A clue as to how the chromatids are distinguished is
the fact that segregation of sister chromatids is randomized
in dnmt2-mutant flies. Various crosses with these mutants
indicate that DNMT2 confers a heritable but DNA-
sequence-independent mark on the sex chromosomes
and that this mark is set during gametogenesis of the par-
ents and maintained during embryogenesis. The value of
this mark in GSCs remains to be revealed.
Yadlapalli and Yamashita (2013). Nature 498, 251–255.This Month in Our Sister JournalsMethods for Use of Low-Coverage Sequencing in
Association Studies
Particularly in an era of shrinking budgets, one has to be
mindful of getting the most bang for the buck from a
research-study design. As genome-wide association studies
begin to target rare variation instead of common variation
as a risk factor for genetic disease, the sample sizes—and
money—needed for detecting this variation inflate and
quickly go out of reach for most investigators. The lower
the frequency of the relevant rare variation, the lower
the power to detect it for a given sample size. Methods
that aggregate rare variation within a certain region ofthe genome have been developed for circumventing this
issue, but these approaches generally cannot be used
with low-coverage, error-prone sequence data. To use
just this kind of cheap-to-produce data, Navon et al.
developed two methods, called LRT and VST, that use
allele counts from sequence data in association tests.
Real and simulated data are used for determining the
best way to maximize power for a given budget, hopefully
bringing these rare-variant studies within reach of more
researchers.
Navon et al. (2013). Genetics. Published online May 1, 2013.
http://dx.doi.org/10.1534/genetics.113.150169.
